Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

Exiqon Launches XploreRNA™ app for Advanced Cross-Database Queries

Published: Tuesday, May 13, 2014
Last Updated: Tuesday, May 13, 2014
Bookmark and Share
XploreRNA™ will soon be available on Android and Windows platforms.

Exiqon A/S has announced the launch of its XploreRNA™ app for advanced cross-database searches, easy interpretation of data and seamless planning of experiments.

XploreRNA™ allows scientists engaged in transcription analysis to scroll any transcript, view splice sites, SNPs, and to zoom in on specific transcripts of interest in an interactive interface. Major databases including Ensembl, miRBase etc., have been cross-annotated to provide for all-in-one searches. Relevant abstracts and original publications have been integrated through PubMed. Products are automatically customized to address search results and readily ordered.

The body of biological data is growing exponentially which makes it challenging for scientists to stay abreast and benefit from big data. To complicate matters different annotations of major databases make cross-database searches time consuming and complicate the identification of relevant genetic information, e.g. microRNA-mRNA interactions. XploreRNA™ overcomes all of these challenges, and is the first in a series of new apps from Exiqon for scientists in both academia and industry.

XploreRNA™ enables “on-the-fly” discussions based on cross-annotated scientific information that is now made available at users fingertips. Results may be easily shared and converted to studies of relevant gene expressions whether for validation purposes or functional analysis.

“An important value proposition for Exiqon is to guide our customers through experimental data, to reach scientific conclusions and make decisions on how to validate data. The XploreRNA™ app does all of this for our customers and requires no prior knowledge about complicated database searches” says Henrik M. Pfundheller, SVP, Sales and Marketing and continues “Should our customers be interested in conducting further experiments the XploreRNA™ will suggest the relevant customized LNA® enhanced products directly available for ordering”.

XploreRNA™ is currently available on iOS platforms but will soon also be available on Android and Windows platforms.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Exiqon Licenses Biomarkers From Aarhus University Hospital
Exiqon A/S has exclusively licensed prostate cancer biomarkers discovered and validated by Aarhus University Hospital, Department of Molecular Medicine (MOMA).
Wednesday, December 03, 2014
Exiqon and Asuragen Sign Agreement for Real-Time PCR Services
The Service Center Agreement allows Asuragen to provide real-time PCR services based on Exiqon’s miRCURY LNA™ Universal RT microRNA PCR products.
Tuesday, June 11, 2013
Exiqon partners with MedTrust Online to Promote Molecular Oncology Diagnostic Services to Oncologists
Exiqon will provide a comprehensive suite of oncology molecular diagnostics services to MedTrust Online's Oncocentric oncology portal.
Wednesday, June 03, 2009
Exiqon A/S appoints permanent CEO

Monday, February 24, 2003
Scientific News
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos